A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the range of single inhaled doses of a new dry
powder product, MDT-637, that are safe and well-tolerated. This includes monitoring effects
on pulmonary function and determination of blood levels of MDT-637 following inhalation.